Corporate Information

Stock Listings

Our Common Stock is listed on the New York Stock Exchange. It is also listed on the London, NYSE Euronext and Swiss stock exchanges, and traded on various United States regional stock exchanges.

Stock Transfer Agent and Registrar

Computershare Trust Company, N.A.
250 Royall Street
Canton, MA 02021
Telephone: 1-800-PFE-9393
Outside the U.S., Canada and
Puerto Rico: 1-781-575-4591

Shareholder Services and Programs

Please contact our Stock Transfer Agent and Registrar with inquiries concerning shareholder accounts of record and stock transfer matters, and also for information on the following services and programs:

  • Shareholder Investment Program
    - direct purchase of Pfizer stock
    - dividend reinvestment
    - automatic monthly investments
  • Book-entry share ownership
  • Direct deposit of dividends

Forward-Looking Information

Please refer to Pfizer's 2009 Form 10-K for a description of the substantial risks and uncertainties related to the forward-looking statements included in this Annual Review. Our Form 10-K is available on our Web site at and on the Securities and Exchange Commission's Web site at

Corporate Responsibility Report

This report provides additional detailed information about how Pfizer conducts business responsibly and engages with stakeholders to advance good health and expand a sustainable business. This report is available online at

Political Action Committee (PAC)

To review our most recent PAC and corporate political contributions report, go online at

Environmental, Health and Safety (EHS)

Our global EHS initiatives, Environmental Sustainability Program and performance metrics may be found online at and in our Corporate Responsibility Report at


Patients, customers and health care professionals who have questions about any of our products should call 1-800-438-1985.

Uninsured or underinsured patients who need help getting their Pfizer medicines should call Pfizer Helpful Answers®, our family of patient assistance programs that provide Pfizer medicines for free or at a savings to patients who qualify. To learn more, visit, or call 1-866-706-2400.

Send Us Your Feedback

We value your views on this Annual Review. Did it help you to better understand Pfizer? Was the information presented in a reader-friendly manner? Please send your comments to [email protected].

You can find more information about Pfizer at Today at Pfizer.

All trademarks appearing in this Annual Review are owned by or licensed to Pfizer Inc or its affiliates.

Wyeth is now part of Pfizer. The merger of local Wyeth and Pfizer entities may be pending in various jurisdictions and integration is subject to completion of various local legal and regulatory obligations. Accordingly, some changes will not become effective outside of the U.S. and Puerto Rico until the relevant go-live date. All content in this message is subject to works council and/or union consultations and other legal requirements where appropriate.

This Annual Review is produced by Pfizer's Policy, External Affairs and Communications group.
Design: Ideas On Purpose, New York   Principal Photography: Catherine Ledner, Victor John Penner, Neil Selkirk